Vision Deficit Is a New Marker of Cognitive Impairment

Despite the frequent combination of cognitive impairments in patients with cataracts and glaucoma, the latter remain insufficiently studied with various visual deficits. The purpose: to study the association of visual deficits in cataracts and primary open–angle glaucoma with cognitive impairment. The clinical study involved 326 elderly patients with cataracts and 318 elderly patients with primary open­angle glaucoma. The diagnosis of this ophthalmology was performed according to generally accepted methods. The degree of cognitive impairment was determined according to the Mini­-Mental­-State­-Examination (MMSE) scale. Visual deficit was assessed by visual acuity without correction. It was found that with low visual deficit (visual acuity without correction of 0,51–0,60 and over 0,61) in the examined patients with cataract, the average score on the MMSE scale varied from 28,7 ± 0,4 to 28,8 ± 0,6 points, and in patients with primary open­-angle glaucoma from 28,3 ± 0.5 to 28,5 ± 0.6 points with no significant differences in both cases. With severe visual deficit (visual acuity without correction to 0,20 and 0,21–0,30), the average score on the MMSE scale varied from 15,2 ± 0,3 to 17,4 ± 0,4 and from 13,8 ± 0,4 to 17,6 ± 0,3, respectively. The correlation coefficient between visual acuity without correction and the average MMSE score in patients with cataract was +0,436, and in patients with glaucoma — r = +0,482. The presence of an association of visual acuity without correction with cognitive dysfunction is also confirmed by regression analysis, which allows us to consider vision deficiency as a marker of cognitive impairment and can be used in monitoring them in patients with cataracts and glaucoma.

1. Agarkov NM, Fabrikantov OL, Lev IV, Nikolashin SI, Aksenov VV. Features of the complement system in primary open‑angle glaucoma and dry eye syndrome in the elderly. Medical Immunology (Russia). 2022;24(2):301–308 (In Russ.). doi: 10.15789/1563‑0625‑FOT‑2394.

2. Agarkov NM, Lev IV, Tanygin MO, Korovin EN. Social functional activity of patients with diabetic retinopathy. Research Results in Biomedicine. 2022;8(4):516– 523 (In Russ.). doi: 10.18413/2658‑6533‑2022‑8‑4‑0‑9.

3. Flaxman SR, Bourne RR, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Silvester A, Stevens GA, Tahhan N, Wong TY, Taylor HR. Global causes of blindness and distance vision impairment 1990‑2020: a systematic review and meta‑analysis. Lancet Glob Health. 2017;5(12):e1221–e1234. doi: 10.1016/S2214109X(17)30393‑5.

4. Tukov AR, Shafransky IL, Prokhorova ON, Ziyatdinov MN. The risk of radiation cataract development in nuclear industry workers participating in the liquidation of the consequences of the Chernobyl accident. Radiation and risk (Bulletin of the National Radiation and Epidemiological Register) 2019;28(1):37–46 (In Russ.). doi: 10.21870/0131‑3878‑2019‑28‑1‑37‑46.

5. Faralli JA, Filla MS, Peters DM. Role of Fibronectin in Primary Open Angle Glaucoma. Cells. 2019;8(12):1518. doi: 10.3390/cells8121518.

6. Fukuoka H, Nagaya M, Toba K. The occurrence of visual and cognitive impairment, and eye diseases in the super‑elderly in Japan: a cross‑sectional single‑center study. BMC Res Notes. 2015;8:619. doi: 10.1186/s13104‑015‑1625‑7.

7. Wostyn P, Audenaert K, Deyn PP. Alzheimer’s disease and glaucoma: is there a causal relationship? Br J Ophthalmol. 2009;93(12):1557–1559. doi: 10.1136/bjo.2008.148064.

8. Jefferis JM, Mosimann UP, Clarke MP. Cataract and cognitive impairment: a review of the literature. Br J Ophthalmol. 2011;95(1):17–23. doi: 10.1136/bjo.2009.165902.

9. Clinical recommendations “Senile cataract”. Moscow: Association of Ophthalmologists, 2020. 52 р. (In Russ.).

10. Nesterov AP, Glaucoma ed. 2‑E. Moscow: Medical Information Agency, 2014. 257 p. (In Russ.).

11. Gorelik SG, Ilnitsky AN, Proschaev KI, Pavlenko EV, Startseva ON, Krivtsunov AN. Questionnaires and scales in gerontology and geriatrics. Gerontology. 2021;9(1):1–88 (In Russ.).

12. Spierer O, Fischer N, Barak A, Belkin M. Correlation Between Vision and Cog‑nitive Function in the Elderly: A Cross‑Sectional Study. Medicine (Baltimore). 2016;95(3):e2423. doi: 10.1097/MD.0000000000002423.

13. Reyes‑Ortiz CA, Kuo YF, DiNuzzo AR, Ray LA, Raji MA, Markides KS. Near vision impairment predicts cognitive decline: data from the Hispanic Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc. 2005;53(4):681– 686. doi: 10.1111/j.1532‑5415.2005.53219.x.

14. Ong SY, Ikram MK, Haaland BA, Cheng CY, Saw SM, Wong TY, Cheung CY. Myopia and cognitive dysfunction: the singapore malay eye study. Invest Ophthalmol Vis Sci. 2013;54(1):799–803. doi: 10.1167/iovs.12‑10460.

15. Haense C, Kalbe E, Herholz K, Hohmann C, Neumaier B, Krais R, Heiss WD. Cholinergic system function and cognition in mild cognitive impairment. Neurobiol Aging. 2012;33(5):867–877. doi: 10.1016/j.neurobiolaging.2010.08.015.

16. Fathy W, Hussein M, Khalil H. Effect of local anesthesia (with lidocaine vs bupivacaine) on cognitive function in patients undergoing elective cataract surgery. Local Reg Anesth. 2018;12:1–6. doi: 10.2147/LRA.S185367.

17. Miyata K, Yoshikawa T, Morikawa M, Mine M, Okamoto N, Kurumatani N, Ogata N. Effect of cataract surgery on cognitive function in elderly: Results of Fujiwara‑kyo Eye Study. PLoS One. 2018;13(2):e0192677. doi: 10.1371/journal.pone.0192677.

18. Mansouri N, Nasrollahi K, Shetabi H. Prevention of Cognitive Dysfunction after Cataract Surgery with Intravenous Administration of Midazolam and Dexmedetomidine in Elderly Patients Undergoing Cataract Surgery. Adv Biomed Res. 2019;8:6. doi: 10.4103/abr.abr_190_18.

19. Ivanov SV, Trofimova EG. The syndrome of falls in patients of ophthalmological departments as an independent medical and social problem. Clinical experience of the twenty = Klinicheskiy opyt dvadcatki. 2015;1:22–27 (In Russ.).